Oculis
phase higher response in both in typical phase population | Oculis
Company
Deck Type
Deck date
October 2022
Slide
18 of 50
Related slides by other companies
Ocuphire Pharma
Investor Day
January 2022
zeta phase design placebo bid | Ocuphire Pharma
Cano Health
Investor Presentation
November 2021
with a higher prevalence of chronic conditions | Cano Health
AngloAmerican
Results
February 2024
temporarily constrained until higher grade ore from new phases | AngloAmerican
TCR2 Therapeutics
Results
September 2022
phase expansion cohorts in solid tumors | TCR2 Therapeutics
Other recent decks by Oculis
See all presentations (6 decks)
Results
August 2023
Investor Presentation
July 2023
Investor Conference
June 2023
Results
May 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io